Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

What does it take to satisfy two regulatory frameworks with one quality system? Explore how pharma consultancy in Indore helps Pithampur manufacturers address USFDA scrutiny, revised Schedule M, validation gaps, and data integrity risks before inspections begin.
Indian drug regulators have inspected over 1,040 sites, and Revised Schedule M now makes WHO-aligned GMP the legal baseline. Learn how to judge pharma consulting companies in India by what still holds when the inspector walks in.
Pharmaceutical manufacturers in Hyderabad face rising expectations for quality, documentation, and regulatory compliance. Explore how expert consulting support can address revised Schedule M requirements, identify GMP gaps, and improve audit preparation, validation, and long-term operational readiness.
Preparing for a GMP inspection takes more than updated documents. Discover how pharma consultancy in Kolkata helps manufacturers address compliance gaps, strengthen quality systems, meet revised Schedule M requirements, and build reliable evidence for CDSCO inspections.
Explore how pharmaceutical consultancy services in Ahmedabad support Schedule M compliance, GMP systems, validation, CDSCO readiness, plant projects, and inspection preparation. Learn what to verify before hiring a specialist and how to match expertise with project risk.
Explore how regulatory strategy, eCTD submissions, health authority interactions, and lifecycle management shape successful pharmaceutical development. This article explains when external expertise adds value, how to choose the right consulting partner, and where stronger planning can reduce regulatory risk.
Explore what a drug safety role involves, from ICSR processing and MedDRA coding to signal detection, GVP compliance, and career development. Learn which skills employers expect, how responsibilities support inspection readiness, and how professionals can enter the field.
Explore how GMP compliance, quality risk management, CAPA, data integrity, and contamination control connect manufacturing decisions to patient protection. This article explains what inspectors look for, which evidence matters, and how strong quality systems reduce pharmaceutical risk.
Pharmaceutical companies face growing pressure to keep pharmacovigilance systems inspection-ready while managing outsourcing, quality gaps, and complex regulatory requirements. This article explains where external expertise adds value, how to evaluate support, and which controls matter most for sustainable compliance.
Explore how DSMBs review safety signals, assess benefit risk, manage interim analyses, and document trial decisions. This guide explains the evidence, controls, and inspection-ready records pharmaceutical teams need to strengthen clinical trial oversight and support regulatory compliance